Journey Medical Corporation (DERM) Q1 2024 Earnings
DERM·Reported May 13, 2024·After market close
Journey Medical Corporation reported Q1 2024 revenue of $13.0M, missed analyst consensus of $14.1M by $1.1M. Diluted EPS came in at $-0.53, missed the $-0.26 consensus by $0.27.
Revenue
$13.0Mmissed by $1.1M
Consensus: $14.1MDiluted EPS
$-0.53missed by $0.27
Consensus: $-0.26
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Journey Medical Corporation's Q1 2024 earnings report.
Journey Medical Corporation (DERM) reported Q1 2024 earnings on May 13, 2024 after market close.
Journey Medical Corporation reported revenue of $13.0M and diluted EPS of $-0.53 for Q1 2024.
Revenue missed the consensus estimate of $14.1M by $1.1M. EPS missed the consensus estimate of $-0.26 by $0.27.
You can read the 10-Q periodic report (0001410578-24-000817) directly on SEC EDGAR. The filing index links above go to sec.gov.